CD74 and breast carcinoma: Here, we introduced CD74 as one of those crucial inhibitors for FAS-mediated apoptosis and our results point to the possibility that the FAS pathway is synergized and activated by the CD74-derived peptide and AKT inhibitor in breast cancer (Figure 4 and Figure 6).